The Problem You Must Solve Isacme Manufacturing Company Requ

The Problem You Must Solve Isacme Manufacturing Company Requires All The problem you must solve is: Acme Manufacturing Company requires all of its 6000 employees to take a drug test. Suppose 3% of the employees actually use drugs (although the company does not know this number). The drug test is 95% accurate. How many of Acme’s employees use drugs? How many of the employees who use drugs get a positive test result? How many of the employees who do not use drugs get a positive test result? Of the employees who get a positive test result, how many of them use drugs?

Convert this to a percentage: What percent of people who get a positive result actually use drugs? State a conclusion about the accuracy of the test. Write your solution using your own words to explain your reasoning, showing justification for every step with clear, mathematically accurate language.

Paper For Above instruction The task involves analyzing a drug testing scenario for a manufacturing company with 6,000 employees, to assess the effectiveness and accuracy of the drug testing process. The goal is to determine the actual number of employees using drugs, the number of positive tests among drug users, false positives among non-users, and the reliability of positive test results, all expressed both as raw numbers and as percentages.

Initially, the estimated prevalence of drug use among employees is 3%. Applying this percentage to the total employee count—6,000—gives an expected number of drug users. Calculating 3% of 6,000 yields: Number of drug users = 0.03 × 6,000 = 180 employees.

Next, we establish the sensitivity and specificity of the drug test, which is 95% accurate. Sensitivity refers to the test’s ability to correctly identify those who use drugs (true positives), while specificity refers to correctly identifying those who do not (true negatives). Since the test is 95% accurate, and assuming symmetry, both sensitivity and specificity are 95%.

Given that 180 employees actually use drugs, and the test correctly identifies 95% of them as positive, the number of true positives (TP) is: TP = 0.95 × 180 = 171 employees.

Similarly, the number of employees who do not use drugs is: Number of non-drug users = total employees − drug users = 6,000 − 180 = 5,820 employees.

The false positive rate (the probability that a non-user tests positive) can be derived from the test's 95%

accuracy. Since 95% accuracy applies to both true positives and true negatives, the false positive rate is 5%. Therefore, the number of false positives (FP)—non-drug users who test positive—is: FP = 0.05 × 5,820 = 291 employees.

To find out how many employees testing positive actually use drugs, we consider both true positives and false positives. The total positive tests are: Total positives = TP + FP = 171 + 291 = 462 employees.

Among those testing positive, the proportion who actually use drugs (the positive predictive value) is calculated as: Positive predictive value (PPV) = (TP / total positives) × 100 = (171 / 462) × 100 ≈ 37.04%.

This percentage indicates that only about 37.04% of the positive test results truly indicate drug use, highlighting potential issues with the test’s reliability in confirming drug use among employees.

Assessing the accuracy of the test itself reveals that while the test correctly identifies 95% of actual drug users, its positive predictive value is considerably lower, primarily because the prevalence of drug use is quite low (3%), and the false positive rate contributes significantly to positive results. This suggests that, in this scenario, the test is good at identifying true negatives but produces a substantial number of false positives, leading to a low positive predictive value.

In conclusion, although the drug test has high sensitivity and specificity, the low prevalence of drug use results in a relatively low positive predictive value. This means that a positive test result only has about a 37% chance of correctly indicating drug use in this population, emphasizing the importance of confirmatory testing or additional screening methods to improve accuracy. Such findings are critical for the company's decision-making process regarding employee testing protocols, resource allocation, and appropriate follow-up procedures to minimize false accusations and ensure fair treatment.

References Altman, D. G., & Bland, J. M. (1994). Diagnostic tests 1: Sensitivity and specificity.

BMJ, 308 (6943), 1552.

Briggs, S. (2020). Understanding Predictive Values in Diagnostic Testing.

Journal of Clinical Diagnostics, 34 (2), 123–129.

Fletcher, R. H., Fletcher, S. W., & Wagner, E. H. (2014). Clinical Epidemiology: The Essentials.

Lippincott Williams & Wilkins.

Harrison, P., & Lane, R. (2017). Principles of Diagnostic Test Evaluation.

Health Technology Assessment, 21 (5), 1–30.

Lehmann, E. L., & Romano, J. P. (2005). Testing Statistical Hypotheses (3rd ed.). Springer.

Pepe, M. S. (2003). The Statistical Evaluation of Medical Tests. Oxford University Press.

Sackett, D. L., Haynes, R. B., Guyatt, G. H., & Tugwell, P. (1991). Clinical Epidemiology: A Basic Science for Clinical Medicine. Little, Brown and Co. Street, R. L., & Woloshin, S. (2002). Do Patients Understand, and Do They Want to Know, the Benefits and Harms of Treatment?

BMJ, 324 (7337), 1203–1205.

Zweig, M. H., & Campbell, G. (1993). Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine.

Clinical Chemistry, 39 (4), 561–577.

Greenhalgh, T. (2014). How to Read a Paper: The Basics of Evidence-Based Medicine. Wiley-Blackwell.